The QualityStocks Daily Friday, April 27th, 2018

Today's Top 3 Investment Newsletters

QualityStocks (BMXC) +112.50%

Small Cap FirM (FCRE) +58.67%

BUYINS.NET (GNPX) +38.27%

The QualityStocks Daily Stock List

GT Biopharma, Inc. (GTBP)

InvestorsHub, Stockhouse, Stockopedia, Insider Financial, and OTC Markets reported on GT Biopharma, Inc. (GTBP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. concentrates on innovative drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. Its lead oncology drug candidate is OXS-1550 (DT2219ARL). The Company owns the global rights to commercialize OXS-1550. GT Biopharma`s current CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, and motion sickness. GT Biopharma is headquartered in Tampa, Florida. The Company’s shares trade on the OTC Markets` OTCQB.

GT Biopharma completed its merger with GTP (Georgetown Translational Pharmaceuticals, Inc.). This merger brought in new management and a class of close-to-market Central Nervous System (CNS) products to GT Biopharma.

A biotechnology company, GT Biopharma is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. The Company is doing so with highly potent biopharmaceutical drugs designed for targeted therapy.

The Company’s CNS platform focuses on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. In addition, the CNS platform focuses on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

GT Biopharma’s OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while lessening damage to normal tissues.

OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed because of the action of cytotoxic payload.

The OXS-3550 TriKE technology was developed by researchers at the University of Minnesota Masonic Cancer Center. This targeted immunotherapy directs immune cells to kill cancer cells while reducing drug-related toxicity.

In late March, GT Biopharma announced that it completed the analysis of pharmacokinetic data from its Phase 1 clinical trial for GTP-004. This is the Company’s promising treatment for the symptoms of myasthenia gravis. Based on these and additional data from the Phase 1 clinical trial, GP Biopharma expects to potentially speed up the start of its Phase 2 trial in MG patients to Q3 2018 from the second half of 2018.

Earlier this month, GT Biopharma announced that the Proof-of-Concept clinical trial with GTP-011 that was started in late February 2018 is completely enrolled. The study is a single-blind, placebo-controlled, cross-over study. The principal goal of the study will be to demonstrate the anti-motion sickness efficacy of transdermal GTP-011 - a novel treatment for the symptoms of motion sickness.

Yesterday, GT Biopharma announced the addition of Ms. Federica O'Brien, CPA to its Board, effective immediately. The expectation is that Ms. O'Brien will chair the Company's Audit Committee. Ms. O'Brien received her B.A. in Accounting from Rutgers University in 1980. She is a member of the American Institute of Certified Public Accountants and the Association of Bioscience Financial Officers.

GT Biopharma, Inc. (GTBP), closed Friday's trading session at $1.54, down 0.65%, on 116,741 volume with 166 trades. The average volume for the last 60 days is 82,285 and the stock's 52-week low/high is $1.44/$36.90.

chart

RenovaCare, Inc. (RCAR)

Zacks, Insider Financial, and MarketWatch reported on RenovaCare, Inc. (RCAR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company’s initial product under development targets the body’s largest organ, the skin. RenovaCare is the developer of the patented CellMist™ and SkinGun™ technologies. These are for isolating and spraying a patient’s own stem cells onto burns and wounds for quick self-healing. RenovaCare is headquartered in New York, New York.

RenovaCare’s flagship technology, the CellMist™ System, employs its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. The Company is developing its CellMist™ System as a promising new option for patients suffering from burns, chronic and acute wounds, and scars.

The CellMist™ System targets patients worldwide who suffer burns, chronic and acute wounds, acne scarring, and skin defects and diseases such as vitiligo. Based on preliminary case studies, CellMist™ System patients can be treated within 90 minutes of entering an emergency room. A patient’s stem cells are isolated, processed, and sprayed onto wound sites for fast healing.

In investigative clinical use in the U.S., SkinGun™ treatments have shown the potential to naturally and quickly heal burns and other serious wounds.

Skin stems cells sprayed with RenovaCare`s patented SkinGun™ device maintain 97.3 percent cell viability. There is no impairment to cell growth or metabolic activity when evaluated in vitro. In 2017, RenovaCare miniaturized the SkinGun™ from the size of a microwave to a device that fits comfortably in one hand.

The Company has a partnership to validate the science behind its unique technology for treatments of wounds, burns, and other skin defects. Its research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT).

The next major milestone for RenovaCare will be its initial Food and Drug Administration (FDA) filing. The FDA filing will advance the Company’s innovative technology towards market. Its initial FDA filing will be to demonstrate the safety and efficacy of its approach for treating wounds utilizing a patient’s own skin cells.

As of February 26, 2018, more than 70 patients in the United States and Europe have been treated with the technology underlying the RenovaCare cell spray system.

In March, RenovaCare announced the appointment of Mr. Harmel S. Rayat, long-time majority stockholder, as Chairman of its Board of Directors. Mr. Rayat has invested almost $6 million in RenovaCare and its stem cell spray technologies.

Mr. Rayat is an established entrepreneur-investor. He is best known for his portfolio of Class-A commercial properties in the United States and Canada. In his role as Chairman, he will work with the Board to support RenovaCare President and Chief Executive Officer, Mr. Thomas Bold, senior Company Management, and clinical and regulatory teams as they work to bring the Company’s cell spray therapies to market.

RenovaCare, Inc. (RCAR), closed Friday's trading session at $4.23, down 0.70%, on 13,924 volume with 45 trades. The average volume for the last 60 days is 168,715 and the stock's 52-week low/high is $2.55/$12.82.

chart

Osprey Gold Development Ltd. (OSSPF)

WatchDog Stocks, Stockhouse, InvestorsHub, Morningstar, MarketWatch, 4-Traders, OTC Markets, Junior Mining Network, Investing News, and Stock Orange reported on Osprey Gold Development Ltd. (OSSPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Osprey Gold Development Ltd. centers on exploring five historically producing gold properties in the Province of Nova Scotia.  Its flagship project is Goldenville, situated in the historical mining district Goldenville, which is one of eastern Canada’s most significant gold belts. The Company has the option to earn 100 percent (subject to certain royalties) in all five properties. This includes the Goldenville Gold Project. Osprey Gold Development has its corporate office in Vancouver, British Columbia.

The Goldenville Gold Project recorded greater than 212,300 ounces of gold production between 1862 and 1942. Goldenville has an updated NI 43-101 inferred resource that includes 2,800,000 tonnes at 3.20 g/t gold for a total of 288,000 ounces of gold (2.8 mil tonnes at 4.96 g/t gold for 447,000 ounces of gold uncapped).

Osprey Gold Development is also exploring the past producing Caribou, Lower Seal Harbour, Miller Lake, and Gold Lake gold projects. Osprey Gold entered into a definitive agreement whereby it has acquired an option to acquire the Caribou Gold Property from John Logan Enterprises Ltd. With this Option Agreement, Osprey Gold may acquire a 100 percent interest (subject to certain royalties) in 16 contiguous mining claims (256 hectares) hosting the past-producing Caribou Property.

The Caribou Gold property is 80 kilometers northwest of Halifax, Nova Scotia and 10 kilometers south of the rural community of Upper Musquodoboit, in Halifax County. The Caribou property contains an historic gold deposit that was intermittently mined between 1869 and 1955.

The Miller Lake Project is roughly 14 kilometers from Goldenville. It has historic production and limited recent exploration. The Gold Lake Project is about 70 kilometers northeast of Halifax. It was discovered in 1867 with minor production taking place in the late 1800’s.

The Lower Seal Harbour project is in Guysborough County, Nova Scotia. This property is around 35 kilometers from Goldenville. Gold at Lower Seal Harbour is found in the veins and the host rocks.

This past September, Osprey Gold announced that it completed the latest drilling program at its Goldenville Gold Project near Sherbrooke, Nova Scotia. The program was expanded from 2,500 meters to 3,044 meters. The expanded drill program included an additional hole at the Mitchell Lake prospect area, 4 kilometers to the east of the main Goldenville resource area, and added holes at the Goldenville resource area.

Recently, Osprey Gold announced that it completed surface work at the Lower Seal Harbour gold project near Goldboro, Nova Scotia. The Company’s initial program included geologic mapping, rock sampling, as well as mobile metal ion (MMI) soil geochemistry.

The program also included compilation and analysis of historic data with the objective of generating targets for future exploration and drill programs. A total of 121 samples from the earlier completed surface program were submitted for assay.

Osprey Gold Development Ltd. (OSSPF), closed Friday's trading session at $0.06, up 5.45%, on 3,000 volume with 1 trade. The average volume for the last 60 days is 27,019 and the stock's 52-week low/high is $0.0485/$0.34.

chart

PetroShare Corp. (PRHR)

DreamTeamNetwork and SmallCapVoice reported previously on PetroShare Corp. (PRHR), and we report on the Company today, here at the QualityStocks Daily Newsletter.

PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The OTCQB-listed Company established to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the U.S. PetroShare has its corporate office in Englewood, Colorado.

PetroShare is expanding its group of properties via organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). The Company’s properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development).

The Company’s current emphasis is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado.

PetroShare acquired an initial acreage position of around 1,280 gross acres (333 net acres) in the core of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field area of NE Colorado.

Additionally, PetroShare’s properties include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) situated in Moffat County. The Company has drilled and completed two producing wells in this prospect.

The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation. PetroShare’s Shook pad development program consists of 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches.

PetroShare has secured the rights-of-way needed to commence pipeline construction and hook up on its Shook pad. In addition, the Company has assembled six additional drill site spacing units (DSUs) with surface use agreements across its South Brighton assets and has roughly 100 permits approved, submitted or in process for operated horizontal wells in the area.

This week, PetroShare provided an update on its operated and non-operated activities in the Wattenberg Field. Mr. Frederick J. Witsell, PetroShare’s President, said, "Activity in the southern portion of the Wattenberg Field remains robust, and thus far in 2018 we have participated in 18 gross horizontal wells (1.6 net to PetroShare's interest) in the Company's Todd Creek Farms area. Most of these wells have been recently completed and are in early production, trending at, or above, our expected production type curves. In addition, the Company is participating in drilling operations on 8 gross horizontal wells in which PetroShare owns a working interest.”

PetroShare Corp. (PRHR), closed Friday's trading session at $1.28, down 3.03%, on 4,300 volume with 8 trades. The average volume for the last 60 days is 4,623 and the stock's 52-week low/high is $0.75/$1.99.

chart

Probe Metals, Inc. (PROBF)

OTC Markets, PennyStockHub, Junior Mining Network, Agoracom, 4-Traders, Investopedia, Investing, Macroaxis, Stockhouse, MarketWatch, InvestorsHub, Morningstar, Barron’s, The Street, Northern Miner, Marketwired, and Barchart reported on Probe Metals, Inc. (PROBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Probe Metals, Inc. involves in the acquisition, exploration, and development of gold properties. The Company controls a strategic land package of more than 1,000-square-kilometers of exploration ground within some of the most prolific gold belts in Quebec - Val d’Or, est Timmins, Casa-Berardi, and Detour Quebec.

Incorporated in 2015, Probe Metals is headquartered in Toronto, Ontario. The Company was established due to the sale of Probe Mines Limited to Goldcorp in March 2015. Goldcorp currently owns an approximately 13.7 percent stake in Probe Metals.

The Company’s main asset is the 100 percent owned Val-d’Or East Gold Project in Quebec. The Val-d'Or East Project comprises the Pascalis, Lapaska, and Megiscane-Tavernier Properties. The Val d'Or East Project consists of 293 claims totaling 11,904 hectares of land, controlled by Probe Metals, situated about 25 kilometers east of the city of Val-d'Or in Quebec.

In addition, Probe Metals has its Detour Quebec Project. This project includes 100 percent owned properties and the 75 percent Probe-SOQUEM JV (Joint Venture) properties.

The Company’s other Projects include the Dubuisson property in Dubuisson Township, Quebec; and the Timmins West in Ontario (the Meunier-144 JV property is in the western part of the prolific Timmins gold camp).

Furthermore, other Projects include the Casa Cameron Project in Quebec. This Project includes properties positioned north of La Sarre, Amos and Lebel-sur-Quevillon, in the northwest area of Quebec.

Additionally, Probe Metals has its Black Creek Chromite Project in Ontario. The Black Creek Chromite deposit is in the James Bay Lowlands in an area known as "The Ring of Fire".

Probe Metals completed the asset purchase of the Aurbel East property from QMX Gold Corporation in July of 2017. This Property is adjacent to its Val-d'Or East Project near Val-d'Or, Quebec.

Probe Metals announced in October of 2017 the completion of the acquisition of the Courvan property from Monarques Gold Corporation. Probe’s landholdings in Val-d’Or are now 327 square kilometers. This makes it one of the largest consolidated land packages in the Val-d'Or Mining Camp.

Recently, Probe Metals announced the filing of a technical report for its Val-d’Or East project entitled, “NI 43-101 Technical Report of Val-d’Or East Property, Abitibi Greenstone Belt, Quebec, Canada”. The Report dated March 29, 2018 was prepared in accordance with National Instrument 43-101 - Standards for Disclosure for Mineral Projects (NI 43-101).

This month, Probe Metals provided new results from the continuing 85,000 meters drill program at its Val-d’Or East project. Results from 44 drill holes, totaling 17,580 meters, were received and indicate continued expansion of the new gold resource along the Pascalis Gold Trend through the application of the Company’s geological model.

Probe Metals, Inc. (PROBF), closed Friday's trading session at $1.01, even for the day, on 82,750 volume with 40 trades. The average volume for the last 60 days is 34,071 and the stock's 52-week low/high is $0.95/$1.4233.

chart

Sigma Labs, Inc. (SGLB)

PennyStocks24, OTCPicks, Wall Street Corner, Greenbackers, OTC Showcase, StockHideout, Breaking Stock Reports, UltimatePennyStock, The Observer, Pennybuster, SuperNova Elite, Top Stock Picks, Penny Stock Rumble, and PennyTrader Publisher reported beforehand on Sigma Labs, Inc. (SGLB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and research and development (R&D) solutions. The Company is a leading developer of proprietary In-Process Quality Assurance™ (IPQA®) software for additive manufacturing (AM).

Sigma Labs is a developer of advanced, in process, non-destructive quality inspection systems for metal-based AM and other advanced manufacturing technologies. The Company consists of foremost scientists and engineers from Los Alamos National Laboratory. Sigma Labs has its headquarters in Santa Fe, New Mexico.

The Company also serves as an AM contract manufacturer. It centers on bringing novel and advanced materials and manufacturing technologies out of the nation's top National Labs and into the marketplace to serve the aerospace, defense, biomedical, power generation, and general industrial sectors.

The Company’s technologies include its innovative PrintRite3D® technology. Sigma Labs is a provider of quality assurance software under the PrintRite3D® brand. This technology allows metals parts to be built by 3D printing or additive manufacturing with fewer flaws and better properties.

Sigma Labs has released Version 3.0.2 of its PrintRite3D INSPECT® In-Process Quality Assurance™ (IPQA®) software. This version of PrintRite3D® is currently available for new installations and upgrades to existing customers.

This latest release features the Company’s new and proprietary Thermal Energy Density™ (TED™) In Process Quality Metric™ (IPQM®). This sets what Sigma Labs views as a new industry standard for quantitatively measuring melt pool and part quality.

In 2017, Sigma Labs announced a commercial agreement with Pratt & Whitney, a unit of United Technologies Corp. (UTX), for its PrintRite3D® software along with participation in the Company’s Early Adopter Program. In addition, Sigma Labs entered into a long term non-exclusive commercial agreement with Additive Industries B. V. of The Netherlands. Additive Industries B.V. now embeds PrintRite3D® software within its additive manufacturing (AM) equipment.

Furthermore, in 2017, Sigma Labs received a contract from Solar Turbines Incorporated, a subsidiary of Caterpillar, Inc. (CAT). Solar Turbines now implements Sigma Labs’ In-Process Quality Assurance™ (IPQA®) technology for the production of gas turbine components.

Moreover, the Company installed its PrintRite3D® INSPECT® software Version 2.0 at Honeywell Aerospace Advanced Manufacturing Engineering Center in Phoenix, Arizona. It also installed its cloud-based PrintRite3D® INSPECT® software Version 2.0 at Woodward, Inc. (WWD) Aircraft Turbine Systems Group.

Sigma Labs belief is that its IPQA®-based process map, combined with customer-specific post-process quality metric data will become an innovative and irreplaceable tool for process engineers looking to quickly and cost effectively establish operating process windows within the larger process map.

Sigma Labs, Inc. (SGLB), closed Friday's trading session at $1.12, up 0.90%, on 23,977 volume with 70 trades. The average volume for the last 60 days is 42,208 and the stock's 52-week low/high is $1.05/$4.48.

chart

OceanaGold Corporation (OCANF)

Stockhouse, TipRanks, InvestorsHub, Stockwatch, Dividend Investor, WalletInvestor, OTC Markets, TradingView, SimVest, Stockscores, SmallCap Network, and Insider Monkey reported on OceanaGold Corporation (OCANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OceanaGold Corporation is a mid-tier, high-margin, multinational gold producer. The Company has assets in the U.S., the Philippines, and New Zealand. Its flagship asset is the Didipio gold-copper mine situated on the island of Luzon in the Philippines. In 2018, the Didipio underground is progressing to plan. OceanaGold has its corporate office in Melbourne, Australia. The Company’s Americas corporate office is in Vancouver, British Columbia.

On the North Island of New Zealand, OceanaGold operates the high-grade Waihi Gold Mine. The Company has started permitting of a 10-year mine life extension at Waihi.

On the South Island of New Zealand, it operates the largest gold mine in the nation at the Macraes Goldfield that consists of a series of open pit mines and the Frasers underground mine.

In the U.S., OceanaGold operates the Haile Gold Mine. This is a top-tier, long-life, high-margin asset located in South Carolina. In 2016, OceanaGold completed the construction of the Haile Gold Mine. It achieved commercial production at Haile in 2017. This year, the Haile process plant expansion is underway.

In addition, the Company has a significant pipeline of organic growth and exploration opportunities in the Americas and Asia-Pacific regions. In 2018, OceanaGold is processing high grade ore from Coronation North.

OceanaGold expects to produce 480,000 to 530,000 ounces of gold and 15,000 to 16,000 tonnes of copper in 2018, with All-In Sustaining Costs (AISC) that range from $725 to $775 per ounce sold.

In December of 2017, eight mining companies engaged in mining, processing and distribution of mineral products in the ASEAN region were recognized at the 1st ASEAN Mineral Awards. These companies were recognized for their achievements to support an environmentally and socially sustainable minerals sector. OceanaGold was awarded the winner of Best Practice in Minerals Processing category.

OceanaGold has its Argentina Joint Ventures (JVs). The Company has the potential to earn-in up to 75 percent on each project in this prolific gold region.

An element of OceanaGold’s business strategy is to develop new reserves and resources at its existing mines from in-pit and near mine exploration or from satellite projects positioned within the present tenements. Another element of its business strategy is to maintain steady-state production in New Zealand to maximize profitability via efficient operations and prudent investment.

OceanaGold Corporation (OCANF), closed Friday's trading session at $2.66, even for the day, on 26,696 volume with 40 trades. The average volume for the last 60 days is 59,419 and the stock's 52-week low/high is $2.27/$3.669.

chart

BioCardia, Inc. (BCDA)

TradingView and MarketWatch reported on BioCardia, Inc. (BCDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of complete solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company, BioCardia is based in San Carlos, California.

BioCardia’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs. In addition, the Helix transendocardial delivery system is being used by a number of clinical partners in biotherapeutic clinical trials.

The Company’s Helix transendocardial delivery system is the top percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene based therapies to treat heart failure, myocardial infarction, ischemia, and also cardiac conduction disorders.

BioCardia’s CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, using a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

CardiALLO uses younger universal donor mesenchymal stem cells. The Company states that CardiALLO may be appropriate for patients who are not optimal candidates for the CardiAMP therapy.

BioCardia has its pivotal Phase III CardiAMP Heart Failure Trial. The CardiAMP Heart Failure Trial is a Phase III, multi-center, randomized, double-blinded, sham-controlled study of up to 260 patients at 40 centers across the nation.

The trial’s primary endpoint is an improvement in six-minute walking distance at 12 months post-treatment. Moreover, the primary endpoint analysis incorporates the impact of major adverse cardiac events and other clinically meaningful events.

In September 2017, BioCardia announced that the independent Data Safety Monitoring Board (DSMB) completed the pre-specified interim analysis of safety outcomes for the first 10 patients treated in the Phase 3 trial of its investigational CardiAMP cell therapy product. The DSMB indicated there were no significant safety concerns with the CardiAMP study results. It recommended that the trial continue, as planned.

In October, BioCardia announced the issuance of United States Patent No. 9,775,963 entitled, “Steerable Endoluminal Devices and Methods.” The design of the Morph steerable, thin-walled catheter shaft technology is to navigate through tortuous anatomy, customize the shape of the catheter to the patient's anatomy and their clinical needs during a procedure, and offer considerable back-up support once positioned. To date, Morph products have been used in over 10,000 clinical procedures globally.

BioCardia, Inc. (BCDA), closed Friday's trading session at $1.70, up 20.57%, on 11,009 volume with 13 trades. The average volume for the last 60 days is 7,905 and the stock's 52-week low/high is $1.30/$8.46.

chart

Millennial Lithium Corp. (MLNLF)

Streetwise Reports, Stockhouse, and Investors Hub reported on Millennial Lithium Corp. (MLNLF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Millennial Lithium Corp. is an emerging exploration and development company listed on the OTC Markets Group’s OTCQB. The Company is concentrating on world class lithium assets in Argentina. Its dedication is to advancing the Pastos Grande Lithium project and the Cauchari East lithium project. Millennial Lithium has its corporate office in Vancouver, British Columbia.

The Company controls more than 35,000 hectares of claims in the heart of the Lithium Triangle, which is home to the globe’s most prolific lithium deposits. The Pastos Grandes Project is Millennial Lithium’s flagship project. This Project is in Salta Province, Argentina.

At present, the Pastos Grandes Project encompasses 6,361 hectares. This makes Millennial Lithium the most active company in this expansive salar. The timeline to production is three years and 9 wells have been drilled and $9 Million spent in development. Millennial has an option to acquire 100 percent of the Pastos Grandes Lithium Project.

The Cauchari East Project is one of the world’s most prospective, shovel-ready lithium brine development projects. It is at the heart of the Lithium Triangle. The ready availability of plenty of regional mining infrastructure offers the prospect of lowered Capex (capital expenditures) and operational expenditures at Cauchari East. Millennial Lithium is now working towards the completion of a 43-101 resource calculation.

Last week, Millennial Lithium report that on December 21, 2017 it entered into the final agreement with the Salta Provincial Energy and Mining Company (REMSA) for the acquisition of 2,492 hectares of claims strategically positioned in the Pastos Grandes Salar and contiguous with the Company’s present land holdings there. Completion of this acquisition will bring Millennial’s holdings at Pastos Grandes to 8,664 hectares.

Today, Millennial Lithium reported that it has met all the goals it set for 2017 to further develop the Pastos Grandes lithium brine project. Production well tests in addition to engineering and process studies are taking place for completion in early-2018 of a Preliminary Economic Assessment (PEA) and to meet the Company's commitments to explore and develop its newly acquired REMSA ground, which added a further 2,492 of highly prospective land.

Millennial Lithium continues working with WorleyParsons Chile S.A. (WP) to deliver a PEA in early 2018. WorleyParsons is a foremost international provider of professional services to resource and energy sectors, and the complex processing industries.

Millennial Lithium Corp. (MLNLF), closed Friday's trading session at $1.65, down 0.61%, on 83,034 volume with 72 trades. The average volume for the last 60 days is 58,409 and the stock's 52-week low/high is $0.883/$3.8694.

chart

Novo Resources Corp. (NSRPF)

Stockhouse, InvestorsHub, MarketWatch, Junior Mining Network, Metals News, Streetwise Reports, and OTC Markets reported on Novo Resources Corp. (NSRPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Novo Resources Corp.’s emphasis is to evaluate, acquire, and explore gold properties. The Company’s current focus is to explore and develop gold projects in the Pilbara region of Western Australia. It has built up a considerable land package encompassing roughly 12,000 sq km. Novo Resources is headquartered in Vancouver, British Columbia.

Additionally, the Company controls a 100 percent interest in roughly 2 sq kms encompassing much of the Tuscarora Au-Ag vein district in the State of Nevada. Novo Resources’ present focus is its Beatons Creek and Marble Bar paleoplacer gold projects in Western Australia.

Novo owns the approximately 10 sq km Beatons Creek Tenements in Western Australia. Wide-ranging test work conducted on Beatons Creek conglomerates indicates high gravity recoveries.

The Company has the right to earn a 70 perccent interest in the roughly 1,800 sq km Pilbara Paleoplacer Gold Project, which includes the Beatons Creek and Marble Bar paleoplacer gold projects, in Western Australia from the Creasy Group.

Furthermore, Novo Resources has acquired, via staking, a 100 percent interest in roughly 6,021 sq kms of mineral rights in the Karratha region. The Company staked exploration applications covering about 7,000 sq kms in the area around Karratha. It controls about an additional 2,000 sq kms elsewhere in the Pilbara region.

Regarding the Karratha Gold Project, Novo has entered into farm-in and joint venture (JV) agreements with Artemis Resources to earn-in on an additional 1,256 sq kms of mineral rights. It has also entered into an option agreement for 100 percent of Welcome Exploration’s gold rights. Moreover, the Company has entered into sale and purchase agreements and farm-in and JV agreements for an 80 percent interest in the Comet Well property.

At the end of November, Novo Resources announced that it satisfied its farm-in exploration expenditure commitment on 38 tenements and tenement applications that comprise the land package subject to the farm-in and JV agreements signed with Artemis Resources. Therefore, the 50:50 JV between Novo Resources and Artemis Resources is now live. Artemis and Novo, by way of their various subsidiaries, will contribute to further exploration on a 50:50 basis.

Last week, Novo Resources announced that tenements at Comet Well were granted by the Department of Mines, Industry Regulation and Safety in Western Australia (DMIRS). The Company is now entitled to begin exploration work on the Comet Well Tenements directed at satisfying conditional farm-in rights Novo holds regarding Comet Well.

Novo Resources will ultimately hold an 80 percent interest in the Comet Well tenements through two JVs. This is if the commitments are satisfied and other conditions under the Comet Well agreements are met. This includes seeking and obtaining consents as required under the Mining Act 1978.

Novo Resources Corp. (NSRPF), closed Friday's trading session at $3.96, up 6.74%, on 78,774 volume with 138 trades. The average volume for the last 60 days is 128,914 and the stock's 52-week low/high is $0.49/$7.0792.

chart

Bemax, Inc. (BMXC)

StockRockandRoll, PennyStockLocks.com, Penny Investor Network, and ResearchOTC reported previously on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bemax, Inc. is a growing international distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Established in 2012, OTCQB-listed Bemax has its head office in Dallas, Georgia.

Bemax’s dedication is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. The Company’s current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax focuses on an extensive and far-reaching global network among wholesalers, large discounting retailers, and supermarkets. Additionally, it focuses on entry into the e-commerce space to reach households directly via subscription orders.

The Company is pursuing opportunities in the fast-growing global Consumer Staples and Household Products Industries. Bemax concentrates on business development and mentoring. It synergizes these models into the household products industry.

Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). NADC is a top U.S. manufacturer of value-priced, eco-friendly disposable baby diapers. With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC.

This week, Bemax announced its financial results for the three months ended February 28, 2018. Revenue for the three months ended February 28, 2018 and 2017 was $102,090 and $24,960, respectively. This represents an increase of $77,130, or 309 percent, in the current period. This increase is because of sales recorded in January 2018.

General and administrative expense was $46,786 and $68,858 for the three months ended February 28, 2018 and 2017, respectively. This represents a decrease of $22,072, or 32.1 percent, in the current period. The decrease in 2018 is attributable to reduced operational costs.

Bemax is extending its sales network to the Indian market. In addition, the Company is completing the process of introducing new complementary private label products. It has recently secured new purchase order totaling $620,000. Furthermore, Bemax is completing negotiations on new purchase orders from existing and prospective customers.

Bemax, Inc. (BMXC), closed Friday's trading session at $0.0017, up 112.50%, on 97,374,140 volume with 325 trades. The average volume for the last 60 days is 15,473,565 and the stock's 52-week low/high is $0.0003/$0.014.

chart

The QualityStocks Company Corner

Uneeqo Inc. (OTC: UNEQ)

The QualityStocks Daily Newsletter would like to spotlight Uneeqo Inc. (UNEQ).

Uneeqo Inc. (OTC: UNEQ) is a Nevada corporation that recently incorporated and registered a new subsidiary, Serpentcoin Limited (“SCL”), in the United Kingdom. Through this subsidiary, Uneeqo has a new focus – a peer-to-peer digital token called “SerpentCoin” built upon a distributed, decentralized public ledger that is viewable and easily audited by transacting parties through unbreakable, encrypted smart contracts.

SerpentCoin is built upon Cardano, a technologically superior blockchain platform developed from a scientific philosophy by a global team of leading academics and engineers. SerpentCoin’s design platform includes several mission critical elements that directly support this forward-thinking technology that is constantly evolving in a fast-moving space.

Projects under development include:

  • Medusa – Each cryptocurrency requires a “wallet,” which is essentially a software application that can be installed on any computer or smartphone, to store tokens. SerpentCoin’s highly-engineered Medusa wallet will contain refined security features developed specifically for Cardano blockchain technology and protects assets with the most advanced cryptography. Medusa will not only support SerpentCoin tokens, but many others as well.
  • Temple – Think of this as a “treasury” which underpins the long-term core value of SerpentCoin. On every transaction through the SerpentCoin platform, 1.5 percent will be deposited in the platform’s Temple. Each quarter, Guardians (or holders of SerpentCoin) will have the chance to vote on how these treasury funds are invested into identified healthcare projects and technologies that benefit humanity.
  • Entwine – This refers to unbreakable smart contracts that allow SerpentCoin Guardians to make agreements on virtually anything while being assured the other party will meet its obligation. Through the use of double-deposit, theft is impossible, no escrow is needed, and no “middlemen” or websites are involved that could hold onto funds.

At the helm of the Uneeqo and SerpentCoin Limited team is Dr. Abel N J Haque, a business development professional with extensive experience in international business in the medical, technology and automotive sectors, as well as a leading consultant in regenerative medicine and cell therapy. Dr. Haque currently serves as an orthopaedic surgery technical consultant for Synergy Medical Technologies where he provides autologous stem cell cartilage transplants under contract to the Royal National Orthopaedic Hospital, University College, Long. In the past, Dr. Haque has held various positions at Wright Medical Europe and Stryker Corporation, along with many of its mergers and acquisitions.

Uneeqo Inc. (UNEQ), closed the day's trading session at $0.045, even for the day. The average volume for the last 60 days is 19,244 and the stock's 52-week low/high is $0.0075/$0.072.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF), a vertically integrated medical cannabis company operating in California and Canada that is committed to delivering safe, consistent, high quality products and services, announces it has engaged the corporate communications expertise of NetworkNewsWire. Also today, NetworkNewsWire released a report on the company detailing how SNNVF is dedicated to providing safe, consistent, high-quality products and services to the Canadian and Californian cannabis markets. To view the full article, visit: http://nnw.fm/Rni8O.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $7.2159, up 10.86%, on 36,457 volume with 135 trades. The average volume for the last 60 days is 38,340 and the stock's 52-week low/high is $6.035/$16.00.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP), a client of NNW focused on developing and out-licensing its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids and nicotine. To view the full publication, titled “Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors,” visit: http://nnw.fm/Oe4Es.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.58, up 2.60%, on 330,869 volume with 270 trades. The average volume for the last 60 days is 228,437 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Choom Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF), a client of NNW focused on channeling the spirit of Hawaii in Canada and building culture around its high-grade handcrafted cannabis brand. To view the full publication, titled “Canadian Cannabis Presents Opportunities in Cultivation and Retail,” visit: http://nnw.fm/H8QaP.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.698, up 3.68%, on 134,863 volume with 178 trades. The average volume for the last 60 days is 133,591 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE), a global technology and value-added solutions group, delivers innovative alternatives to cash payments through its ecommerce and retail payment transaction and processing brands such as PayOnline and Unified Payments. To view the full article, visit: http://nnw.fm/zt6Q5. Also today, NetworkNewsWire released a report on the company detailing how NETE continues to master the art of the transaction by delivering valuable payment solutions to merchants and consumers.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.98, off by 0.50%, on 174,095 volume with 1,066 trades. The average volume for the last 60 days is 971,427 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH).

Specialized fintech company and consumer loan provider IEG Holdings Corp. (OTCQB: IEGH) issues and services direct, unsecured personal loans under the brand name “Mr. Amazing Loans” through its state-licensed operating subsidiary, Investment Evolution Corporation. Residents of 20 states (and counting) are able to apply online for consumer loans of either $5,000 or $10,000 by simply going to the company’s website and application portal at www.MrAmazingLoans.com.

IEG Holdings Corp. (OTCQB: IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand “Mr. Amazing Loans.” Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company’s Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company’s loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans’s terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer’s checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH’s other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings’ chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young’s 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting.

IEG Holdings Corp. (IEGH), closed the day's trading session at $0.27, even for the day. The average volume for the last 60 days is 18,535 and the stock's 52-week low/high is $0.14/$4.19.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (VRCP).

Virtual Crypto Technologies Inc. (OTCQB: VRCP) proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.20, even for the day, on 48,922 volume with 25 trades. The average volume for the last 60 days is 27,069 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains focused on developing its strategic portfolio. To view the full article, visit: http://nnw.fm/2hEsO.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) (https://globalhempgroup.com/hempagro/) in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.10, even for the day, on 86,530 volume with 25 trades. The average volume for the last 60 days is 168,585 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News

chart

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) is preparing to mine lithium at Cat Lake, Manitoba. To view the full article, visit: http://nnw.fm/lp5IB.

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.408, up 2.00%, on 117,215 volume with 35 trades. The average volume for the last 60 days is 193,420 and the stock's 52-week low/high is $0.0741/$1.46.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTC: MCOA) develops industrial hemp-based CBD products, which will be marketed at competitive prices through an affiliate-marketing program, traditional retail and direct-to-consumer marketing campaigns targeting the giant legal cannabis market. To view the full article, visit: http://nnw.fm/5Qe6S.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.03, off by 2.91%, on 2,919,767 volume with 178 trades. The average volume for the last 60 days is 5,628,066 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News

chart

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Healthcare technology company Zenosense (OTC: ZENO) is well positioned to capitalize on the projected growth in the global point-of-care (“POC”) diagnostics market, forecast to grow at a CAGR of 10 percent, from $23.71 billion in 2017 to $38.13 billion in 2022 according to a recent Research and Markets report (http://nnw.fm/o0fNq), through the development and commercialization of its MIDS Cardiac device. To view the full article, visit: http://nnw.fm/uv74S.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.42, off by 1.16%, on 68,176 volume with 26 trades. The average volume for the last 60 days is 101,348 and the stock's 52-week low/high is $0.2021/$0.895.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.